0001415889-21-002621.txt : 20210520
0001415889-21-002621.hdr.sgml : 20210520
20210520183934
ACCESSION NUMBER: 0001415889-21-002621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210518
FILED AS OF DATE: 20210520
DATE AS OF CHANGE: 20210520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brophy Michael Burkes
CENTRAL INDEX KEY: 0001697362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21945975
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-05202021_030520.xml
X0306
4
2021-05-18
0001604821
Natera, Inc.
NTRA
0001697362
Brophy Michael Burkes
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
CHIEF FINANCIAL OFFICER
Common Stock
2021-05-18
4
M
0
10564
10.41
A
99222
D
Common Stock
2021-05-18
4
M
0
5035
9.29
A
104257
D
Common Stock
2021-05-18
4
M
0
5208
19.68
A
109465
D
Common Stock
2021-05-18
4
S
0
15240
93.1604
D
94225
D
Common Stock
2021-05-18
4
S
0
5567
93.6765
D
88658
D
Stock Option (right to buy)
10.41
2021-05-18
4
M
0
10564
0
D
2027-06-08
Common Stock
10564
0
D
Stock Option (right to buy)
9.29
2021-05-18
4
M
0
5035
0
D
2028-03-08
Common Stock
5035
10070
D
Stock Option (right to buy)
19.68
2021-05-18
4
M
0
5208
0
D
2029-03-21
Common Stock
5208
23959
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.51 to $93.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.5150 to $93.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-05-20